Harvard Bioscience, Inc.
HBIO
$0.76
$0.011.55%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.23M | -2.28M | -50.34M | 18.00K | -4.80M |
| Total Depreciation and Amortization | 1.32M | 1.62M | 1.66M | 1.76M | 1.82M |
| Total Amortization of Deferred Charges | 357.00K | 210.00K | 131.00K | 98.00K | 89.00K |
| Total Other Non-Cash Items | 344.00K | 422.00K | 48.03M | 442.00K | 1.53M |
| Change in Net Operating Assets | 290.00K | 2.79M | 3.51M | -593.00K | 528.00K |
| Cash from Operations | 1.08M | 2.76M | 2.99M | 1.73M | -842.00K |
| Capital Expenditure | -207.00K | -89.00K | -513.00K | -301.00K | -880.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -141.00K | -144.00K | -170.00K | -165.00K | -231.00K |
| Cash from Investing | -348.00K | -233.00K | -683.00K | -466.00K | -1.11M |
| Total Debt Issued | -- | -- | -- | 0.00 | 3.25M |
| Total Debt Repaid | -1.00M | -1.00M | -1.00M | -1.00M | -1.00M |
| Issuance of Common Stock | 0.00 | 46.00K | -- | 161.00K | 15.00K |
| Repurchase of Common Stock | -24.00K | 0.00 | -75.00K | -518.00K | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -254.00K | -304.00K | -129.00K | 0.00 | -161.00K |
| Cash from Financing | -1.28M | -1.26M | -1.20M | -1.36M | 2.10M |
| Foreign Exchange rate Adjustments | -83.00K | 632.00K | 339.00K | -363.00K | 370.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -625.00K | 1.90M | 1.44M | -461.00K | 521.00K |